CAPTRUST Financial Advisors’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-30,973
| Closed | -$732K | – | 2730 |
|
|
2023
Q4 | $732K | Sell |
30,973
-14,536
| -32% | -$343K | ﹤0.01% | 1473 |
|
|
2023
Q3 | $679K | Buy |
+45,509
| New | +$679K | ﹤0.01% | 1438 |
|
|
2022
Q3 | – | Sell |
-5,628
| Closed | -$17K | – | 4331 |
|
|
2022
Q2 | $17K | Sell |
5,628
-1,628
| -22% | -$4.92K | ﹤0.01% | 3469 |
|
|
2022
Q1 | $23K | Hold |
7,256
| – | – | ﹤0.01% | 3312 |
|
|
2021
Q4 | $25K | Buy |
7,256
+1,241
| +21% | +$4.28K | ﹤0.01% | 3153 |
|
|
2021
Q3 | $22K | Hold |
6,015
| – | – | ﹤0.01% | 3104 |
|
|
2021
Q2 | $26K | Hold |
6,015
| – | – | ﹤0.01% | 2946 |
|
|
2021
Q1 | $27K | Buy |
6,015
+2,515
| +72% | +$11.3K | ﹤0.01% | 2824 |
|
|
2020
Q4 | $20K | Hold |
3,500
| – | – | ﹤0.01% | 2260 |
|
|
2020
Q3 | $25K | Buy |
+3,500
| New | +$25K | ﹤0.01% | 1887 |
|